HCA
TWST icon

Harbor Capital Advisors’s Twist Bioscience TWST Stock Holding History

Harbor Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.48M Buy
53,282
+15,883
+42% +$1.03M 0.37% 52
2026
Q1 		$1.78M Buy
+37,399
New +$1.68M 0.14% 214
2024
Q1 		– Sell
-25,282
Closed -$932K – 856
2023
Q4 		$932K Sell
25,282
-615
-2% -$14.2K 0.18% 145
2023
Q3 		$525K Buy
25,897
+1,062
+4% +$23.3K 0.11% 219
2023
Q2 		$508K Buy
+24,835
New +$372K 0.1% 243

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Harbor Capital Advisors's TWST Position: Q2 2026 in Review

Harbor Capital Advisors increased its Twist Bioscience (TWST) stake by 42% in Q2 2026, buying an estimated $1.03M and bringing the position to 53,282 shares worth $5.48M. The position accounts for 0.37% of the portfolio, ranked #52.

Harbor Capital Advisors first reported a position in TWST in Q2 2023 and has held it in 5 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Harbor Capital Advisors held 53,282 shares of Twist Bioscience worth $5.48M as of Q2 2026.
  • Harbor Capital Advisors bought 15,883 Twist Bioscience shares in Q2 2026, an estimated $1.03M.
  • Twist Bioscience made up 0.37% of Harbor Capital Advisors's portfolio in Q2 2026, its #52 holding.
  • Harbor Capital Advisors first reported a position in Twist Bioscience in Q2 2023 and has held it in 5 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.